About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiology research group of the Vall d'Hebron Research Institute (VHIR) focuses on the study of microbiological aspects —in basic, translational and clinical research— that could improve the outcome of patients with infectious diseases.
Our priority research areas are:
We actively collaborate with other microbiology laboratories, health services, national and international centres and organizations, as well as with the different research networks of the Carlos III Health Institute in Spain.
In addition, we carry out an important activity in the surveillance of the genotypic and phenotypic evolution of microorganisms present in the community in terms of their virulence, transmissibility, antigenic escape and antimicrobial resistance, in collaboration with public administrations, both at the national and international level.
IP: Elena Sulleiro Igual Collaborators: Pau Bosch Nicolau Funding agency: Instituto de Salud Carlos III Funding: 108750 Reference: PI23/01942 Duration: 01/01/2024 - 31/12/2026
IP: Maria Francesca Cortese Collaborators: Maria Jose Herrero Mata, Elena Vargas Accarino, Maria Buti Ferret, Ariadna Rando Segura, Jordi Llaneras Artigues, Adriana Palom Agusti, Francesc Rudilla Salvador, David Tabernero Caellas, Beatriz Pacín Ruiz Funding agency: Instituto de Salud Carlos III Funding: 220000 Reference: PI23/01065 Duration: 01/01/2024 - 30/06/2028
IP: Joaquin Burgos Cibrian Collaborators: Ester del Barrio Tofiño, David Campany Herrero, Paula Suanzes Diez Funding agency: Instituto de Salud Carlos III Funding: 190000 Reference: PI23/01184 Duration: 01/01/2024 - 30/06/2028
IP: Ibai Los Arcos Bertiz Collaborators: M Teresa Martin Gomez, Yolanda Villena Ortiz, Javier Gomis Rodriguez, Judith Sacanell Lacasa, Marta Zapata Ortega, David Campany Herrero, Leire Sanchez Corujo Funding agency: Instituto de Salud Carlos III Funding: 37500 Reference: PI23/01467 Duration: 01/01/2024 - 30/06/2028
The technology could help make stool sample screening more comprehensive and facilitate the identification of parasitic findings for subsequent expert review.
The initiative focuses on awareness, prevention, and the normalization of sexual health check-ups among young people.
All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.
